Catalyst Wire Dossier Catalyst Wire Dossier

CH505 TF chTrimer vaccine (stabilized)

· NIAID
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CH505 TF chTrimer vaccine (stabilized), covering 2026-03-03 to 2026-03-03. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity of Stabilized CH505 TF chTrimer Vaccination in Adults Living With HIV-1 on Suppressive Antiretroviral Therapy [Phase 1]

See pricing